Health

  • June 12, 2026

    Wellpoint Data Breach Suit Says Delay Elevated Fraud Risk

    A Washington resident accused insurer Wellpoint Washington Inc. and health services provider Independent Clinics of Washington of failing to adequately protect patient information from a June 2025 cyberattack, claiming in a proposed nationwide class action Thursday that Wellpoint also neglected to inform subscribers until nearly a year after the breach.

  • June 12, 2026

    Disability Rights Orgs. Seek To Halt NY, Ill. 'Aid-In-Dying' Laws

    Disability rights organizations hit the governors of New York and Illinois with a pair of federal lawsuits seeking to stop new laws in each state from taking effect that would allow patients with terminal illnesses to seek a doctor's assistance in ending their lives.

  • June 12, 2026

    Aetna Can't Nix Unfair Practices Claims In Medical Billing Row

    A Washington acupuncture clinic and doctor accused of submitting fraudulent bills for medical services may proceed with their counterclaims against Aetna for unfair trade practices under the state's Consumer Protection Act, a federal court ruled.

  • June 12, 2026

    $1.9M Deal In Health System Retirement Suit Gets 1st OK

    A Michigan federal judge granted initial approval to a $1.9 million deal between a health system and a proposed class of employee retirement plan participants who alleged underperforming investment options violated federal benefits law, greenlighting a deal that was first submitted to the court for approval in late April.

  • June 12, 2026

    Lowe's Customer Says Raccoon Attack Led To Vaccine Injury

    A Pittsburgh-area Lowe's in 2024 allegedly failed to catch and test for rabies a trio of raccoons, one of which had attacked a customer, leading her to require multiple vaccine injections that she blamed for additional injuries, according to a lawsuit filed in Pennsylvania state court.

  • June 12, 2026

    Taxation With Representation: Gibson Dunn, Davis Polk, S&C

    In this week's Taxation With Representation, SpaceX prices a $75 billion initial public offering at its designated price range, Apollo Global Management leads a capital commitment for a Broadcom initiative to build artificial intelligence infrastructure for companies including Anthropic, and pharma giant GSK acquires cancer therapy specialist Nuvalent.

  • June 12, 2026

    Cooper Health To Pay $735K Over 2024 Data Breach

    The Cooper Health System has agreed to pay $735,000 to settle proposed class actions over a May 2024 data breach that allegedly resulted from the failure to properly safeguard individuals' protected information.

  • June 12, 2026

    UK Litigation Roundup: Here's What You Missed In London

    The past week in London has seen the FCA bring a claim against a fund manager it accused of providing investment services despite having been banned, an Ardmore unit sue a contractor two days before the construction group's collapse, and shipping and cruise giant MSC hit back at an entertainment company following separate intellectual property litigation in the U.S. Here, Law360 looks at these and other new claims in the U.K.

  • June 12, 2026

    Akin Recruits Corporate Pro In Dallas From Katten

    Akin Gump Strauss Hauer & Feld LLP has expanded its corporate practice with a former Katten Muchin Rosenman LLP attorney in Dallas.

  • June 11, 2026

    USAA Says Therapist's Policy Doesn't Cover Ex-Lover's Death

    USAA argued in a Washington federal lawsuit Wednesday that the insurer has no duty to defend a therapist in a wrongful death action brought by the estate of a former patient who was allegedly shot and killed by the therapist's new boyfriend amid the fallout from a "tumultuous" romantic relationship.

  • June 11, 2026

    Ed. Dept. Tries New Tack To Scrap K-12 Mental Health Grants

    The U.S. Department of Education pressed ahead with its plan to end up to a billion dollars in school mental health grants, arguing Wednesday that a Seattle federal judge's December 2025 injunction barring the discontinuation of the grants shouldn't block the government from canceling the contracts outright.

  • June 11, 2026

    AbbVie Loses Colorado 340B Drug Pricing Law Challenge

    A Colorado federal judge on Wednesday dismissed all of AbbVie Inc.'s claims against the state over its federal 340B drug pricing law, finding that the Colorado law isn't federally preempted and courts across the country have settled the issue.

  • June 11, 2026

    Fla. Dispensary Says Data Privacy Suit Is Meritless

    A medical marijuana patient can't sue Florida dispensary Sunburn Cannabis for secretly sharing his health data with Google LLC, the dispensary argued to a federal court this week, saying he consented to the tracking via its website's privacy policy.

  • June 11, 2026

    Fla. Hospital Antitrust Case Paused For Cert. Denial Appeal

    Patients who have accused hospital operator Health First of illegally fending off competition by preventing doctors from referring patients to rivals have convinced a Florida federal judge to put their lawsuit on hold while they challenge her decision to deny them class certification.

  • June 11, 2026

    11th Circ. Seeks Fla., Ga. Justices' Input On Opioid Coverage

    The Eleventh Circuit on Thursday asked justices in Georgia and Florida to weigh in on whether commercial general liability insurers must defend and indemnify Publix Super Markets Inc. and a Georgia-based generic-drug wholesaler against suits claiming they improperly distributed opioids.

  • June 11, 2026

    Mich. Judge Denies Law Firm's Bid To Toss Data Breach Suit

    A Michigan law firm's bid to toss a proposed class action alleging that it allowed a cybersecurity breach that exposed its clients' personal and medical information was denied Thursday by a federal judge who also granted the lead plaintiff's request to amend his complaint.

  • June 11, 2026

    Stop & Shop Parent Pays $40M On Inflated Drug Price Claims

    Stop & Shop's parent company will pay $40 million to resolve allegations it violated the False Claims Act by failing to report discounted prescription drug prices as "usual and customary" in claims submitted to federal Medicare, Medicaid and TRICARE programs, which resulted in overcharges, the U.S. Department of Justice announced Wednesday.

  • June 11, 2026

    Chinese Biopharma Sues Over National Security Threat Label

    Chinese pharmaceutical company WuXi AppTec sued the U.S. Department of Defense on Thursday, asking a D.C. federal court to set aside the agency's designation of the company as a Chinese military company, which it said was done "without a lawful or factual basis."

  • June 11, 2026

    23andMe To Pay $46.7M To Resolve Data Breach Claims

    The plan administration trust created under the Chapter 11 plan of DNA-testing company 23andMe has struck a deal to pay $46.7 million to data breach claimants, saying the move brings 23andMe one step closer to resolving the fallout of a massive data breach in 2023.

  • June 11, 2026

    Hospital Co. Accused Of Misusing Forfeited 401(k) Funds

    A Northwell Health Inc. subsidiary violated federal benefits law by using millions of dollars in forfeited 401(k) funds to offset its contribution obligations and allowing the $1.2 billion plan's recordkeeper to be overpaid, according to a proposed class action in Connecticut federal court.

  • June 11, 2026

    5th Circ. Backs $158M Healthcare Fraud Scheme Convictions

    The Fifth Circuit affirmed convictions for two men found guilty in a $158 million healthcare scheme where false claims were submitted for illegitimate compound medications, ruling Wednesday there was sufficient evidence for jurors to find they conspired to defraud federal workers' compensation programs and Blue Cross Blue Shield.

  • June 11, 2026

    HHS OIG Reports 'Concerning' Medicare Advantage Denials

    A pair of reports released by the inspector general for the U.S. Department of Health and Human Services on Thursday found that UnitedHealth Group, Humana and CVS Health logged some of the highest prior authorization denial rates among their Medicare Advantage peers for post-acute care.

  • June 11, 2026

    Legislative Update: Cannabis And Psychedelics Bill Roundup

    Lawmakers in multiple states advanced legislation reining in products derived from the kratom leaf, Pennsylvania lawmakers rejected a cannabis regulation bill, and Rhode Island's governor signed into law legislation eliminating residency requirements from the state's cannabis social equity program. Here are the major moves in cannabis and psychedelics legislation from the past week.

  • June 11, 2026

    Conn. Justices Order New Trial In $13.2M Estate Tax Fight

    The Connecticut Supreme Court on Thursday ordered a new trial over the state's $13.2 million tax assessment against the estate of a health insurance executive who died in Florida, saying a trial judge should have applied a lower standard of proof when determining the executive's state of residence.

  • June 11, 2026

    Braidwood Files New Challenge To ACA Birth Control Mandate

    For-profit healthcare company Braidwood Management and several individuals sued the government in Texas federal court to challenge no-cost contraception coverage requirements under the Affordable Care Act, arguing that the court should enjoin enforcement of the policy because it burdened their faith in violation of federal religious freedom law.

Expert Analysis

  • Series

    Alpine Skiing Makes Me A Better Lawyer

    Author Photo

    Skiing has shaped habits I rely on daily as an attorney — focus, resilience and the ability to remain steady when circumstances shift rapidly — and influences the way I approach legal strategy, client counseling and teamwork, says Isaku Begert at Marshall Gerstein.

  • Weighing The Practical Implications Of SC Kids' Privacy Law

    Author Photo

    South Carolina's recently enacted Age-Appropriate Code Design Act includes a unique provision: a private right of action for certain violations, but its practical effect remains uncertain, as courts and litigants grapple with complex questions of standing, causation and the definition of actionable harm, say attorneys at K&L Gates.

  • FDA Guidance May Move Goalposts For Form 483 Responses

    Author Photo

    New draft guidance from the U.S. Food and Drug Administration provides formal insight on how drug manufacturers are expected to respond to Form 483s, raising some concerns about the agency's timelines and expectations, say attorneys at Cooley.

  • 2 Strands Of Patent Law In High Court's 'Skinny Label' Case

    Author Photo

    Amarin v. Hikma, which is set for oral argument in the U.S. Supreme Court this month, highlights the distinction between two different strands of intellectual property law — analogizing a patent to either a property deed or a home, says Jonas McDavit at Spencer West.

  • Telehealth Suit May Redraw Rules For Physician Classification

    Author Photo

    A new class action in California federal court, Cioppettini v. Mochi Medical, alleging a telehealth company misclassified providers as independent contractors, suggests that traditional markers of physician independence may not apply to telehealth, say attorneys at Reed Smith.

  • Legal Theories In Social Media Verdicts Hold Clues On Impact

    Author Photo

    Although the two verdicts in cases in New Mexico and California involving Meta and Google are being lumped together, they rest on fundamentally different legal theories, and that distinction determines how their effects may be felt in other jurisdictions, says Mark Morgan at Day Pitney.

  • Senior Housing Demands A Distinct Dealmaking Playbook

    Author Photo

    An aging population and evolving state regulations underscore a critical reality that senior housing assets can undergo operational or compliance shifts during dealmaking, highlighting the need for unique contractual safeguards like expanded disclosures, anchored notice obligations, and targeted closing conditions and remedies, say attorneys at Goodwin.

  • Why MDLs Slow Down — And How To Speed Them Up

    Author Photo

    Multidistrict litigation has become central to mass tort practice, but as MDLs grow in size and complexity, so do delays and costs — so tools like the new federal rule governing MDLs, targeted use of special masters and strategically deployed Lone Pine orders are more essential than ever, say attorneys at Ice Miller.

  • A Check-Up On HHS' Push To Implement AI Infrastructure

    Author Photo

    The U.S. Department of Health and Human Services has made some headway in its efforts to implement artificial intelligence across its agencies, but will have to overcome a number of near-term tests in order to be successful, says Theodore Thompson at Stinson.

  • What A Court Doc Audit Reveals About Erroneous Filings

    Author Photo

    My audit of 1,522 court documents from last month found that over 95% contained at least one verifiable error, with fewer than 1% showing clear indicators of artificial intelligence use — highlighting above all else that lawyers may want to focus most on strengthening their review processes, says Elliott Ash at ETH Zurich.

  • Exploring When Fraud Asset Freezes Limit Right To Pick Atty

    Author Photo

    The defendant’s claim in the Seventh Circuit’s pending U.S. v. Shah case that the government restrained his assets until he couldn’t afford his chosen counsel presents a useful case study in how criminal forfeiture procedure interacts with U.S. Supreme Court rulings on Sixth Amendment rights and appealing complex fraud convictions, says Elisha Kobre at Sheppard.

  • Similar-Looking Designs May Not Always Prove Infringement

    Author Photo

    The Federal Circuit's recent decision in Range of Motion Products v. Armaid is a reminder that even a strikingly similar design might not be found to infringe upon a patented design once design features driven by functionality are filtered out from consideration, say attorneys at BCLP.

  • Series

    Mich. Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    Michigan's financial services sector saw several significant developments in 2026's first quarter, including the state Department of Insurance and Financial Services' issuance of a bulletin on the use of artificial intelligence and the Michigan House's introduction of a bill based on the Model Money Transmission Modernization Act, say attorneys at Dykema.

  • The Road Ahead For Drug Development In The US

    Author Photo

    Against the backdrop of drug manufacturers potentially looking to move development efforts overseas, the U.S. Food and Drug Administration's latest guidance on new approach methodologies signals the FDA is likely to be receptive to industry innovation that makes U.S.-based drug development faster or less expensive, creating opportunities and compliance risks for tech companies, say attorneys at Morgan Lewis.

  • FDA's Crackdown On Drug Ads Conflicts With Precedent

    Author Photo

    Recent U.S. Food and Drug Administration warning letters to drug manufacturers targeting direct-to-consumer advertising raise significant constitutional concerns, and directly clash with prior FDA stances, say attorneys at Sidley.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.